CYSTADROPS 3.8 MGML Israel - English - Ministry of Health

cystadrops 3.8 mgml

medison pharma ltd - mercaptamine as hydrochloride - ophthalmic solution - mercaptamine as hydrochloride 3.8 mg - mercaptamine - cystadrops is indicated for the treatment of corneal cystine crystal deposits in adults and children from 2 years of age with cystinosis.

Cystaran 0.44% eye drops United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

cystaran 0.44% eye drops

imported (united states) - mercaptamine hydrochloride - eye drops - 4.4mg/1ml

Cystagon European Union - English - EMA (European Medicines Agency)

cystagon

recordati rare diseases - mercaptamine bitartrate - cystinosis - other alimentary tract and metabolism products, - cystagon is indicated for the treatment of proven nephropathic cystinosis. cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

Procysbi European Union - English - EMA (European Medicines Agency)

procysbi

chiesi farmaceutici s.p.a - mercaptamine bitartrate - cystinosis - other alimentary tract and metabolism products, - procysbi is indicated for the treatment of proven nephropathic cystinosis. cysteamine reduces cystine accumulation in some cells (e.g. leukocytes, muscle and liver cells) of nephropathic cystinosis patients and, when treatment is started early, it delays the development of renal failure.

Dropcys European Union - English - EMA (European Medicines Agency)

dropcys

lucane pharma - mercaptamine - corneal diseases; cystinosis - treatment of corneal cystine deposits,

CYSTADROPS SOLUTION Canada - English - Health Canada

cystadrops solution

recordati rare diseases canada inc - cysteamine (cysteamine hydrochloride) - solution - 0.37% - cysteamine (cysteamine hydrochloride) 0.37% - eent drugs, miscellaneous